|Articles|February 15, 2023
- Applied Clinical Trials-02-01-2023
- Volume 32
- Issue 1/2
Applied Clinical Trials January/February 2023 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
The Benefits and Limitations of Clinical Data Platformsover 2 years ago
Progress Report: Pharma Adoption of Data Analyticsover 2 years ago
FDA Interactions With Industry Under the Microscopeover 2 years ago
2023 SCOPE: It’s an Orlando Thingalmost 3 years ago
Get it Right Next Time? EU Legislation Under Critical Reviewalmost 3 years ago
Advances in eSource Interoperability Between EHR and EDCalmost 3 years ago
Identifying Patient NeedsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
4
Designing Feasible Protocols with Real-World Data
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
